Odyssey Therapeutics, Inc. · NASDAQ:ODTX
George Simeon bought 555,555 and sold 1,780 Odyssey Therapeutics, Inc. shares (Form 4)
Traded May 11, 2026 · Filed May 11, 2026
On May 11, 2026, George Simeon (10% owner) bought 555,555 and sold 1,780 Odyssey Therapeutics, Inc. shares, leaving 1,014,851 shares. Filed May 11, 2026 (Form 4).
- Bought
- 555,555 shares (US$10M at US$18.00)
- Sold
- 1,780 shares (US$32,040 at US$18.00)
- Holding after
- 1,014,851 shares (held indirectly)
- Trading plan
- No
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 11, 2026 | Common Stock | Conversion | 474,048 | 474,048 | Indirect | |
| May 11, 2026 | Common Stock | Conversion | 139,366 | 613,414 | Indirect | |
| May 11, 2026 | Common Stock | Conversion | 59,692 | 673,106 | Indirect | |
| May 11, 2026 | Common Stock | Conversion | 61,762 | 734,868 | Indirect | |
| May 11, 2026 | Common Stock | Conversion | 683,817 | 1,418,685 | Indirect | |
| May 11, 2026 | Common Stock | Option exercise | 191,541 | 1,610,226 | Indirect | |
| May 11, 2026 | Common Stock | Sale | 1,065 | US$18.00 | 1,609,161 | Indirect |
| May 11, 2026 | Common Stock | Buy | 222,222 | US$18.00 | 1,831,383 | Indirect |
| May 11, 2026 | Common Stock | Conversion | 118,512 | 118,512 | Indirect | |
| May 11, 2026 | Common Stock | Conversion | 255,823 | 374,335 | Indirect | |
| May 11, 2026 | Common Stock | Conversion | 204,658 | 204,658 | Indirect | |
| May 11, 2026 | Common Stock | Conversion | 20,582 | 225,240 | Indirect | |
| May 11, 2026 | Common Stock | Conversion | 166,168 | 391,408 | Indirect | |
| May 11, 2026 | Common Stock | Option exercise | 49,850 | 441,258 | Indirect | |
| May 11, 2026 | Common Stock | Sale | 277 | US$18.00 | 440,981 | Indirect |
| May 11, 2026 | Common Stock | Buy | 133,333 | US$18.00 | 574,314 | Indirect |
| May 11, 2026 | Common Stock | Conversion | 463,106 | 463,106 | Indirect | |
| May 11, 2026 | Common Stock | Conversion | 273,527 | 736,633 | Indirect | |
| May 11, 2026 | Common Stock | Option exercise | 78,656 | 815,289 | Indirect | |
| May 11, 2026 | Common Stock | Sale | 438 | US$18.00 | 814,851 | Indirect |
| May 11, 2026 | Common Stock | Buy | 200,000 | US$18.00 | 1,014,851 | Indirect |
Source
Related
- Odyssey Therapeutics, Inc.
- George Simeon
- Odyssey Therapeutics, Inc. shareholders
- Schedule 13G · FMR LLC · Jun 5, 2026
- Schedule 13D · SR One Capital Management, LLC · May 18, 2026
- Schedule 13D · Tpg Gp A, LLC · May 18, 2026
- Schedule 13G · Lightspeed Venture Partners XV-B (Ignite), L.P. · May 18, 2026
- Schedule 13D · Jeito II S.L.P. · May 15, 2026